• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过Tp103途径触发细胞毒性T淋巴细胞和自然杀伤细胞依赖于T细胞受体/CD3复合物的表达。

Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex.

作者信息

Fleischer B, Sturm E, De Vries J E, Spits H

机构信息

Department of Medical Microbiology and Immunology, University of Ulm, FRG.

出版信息

J Immunol. 1988 Aug 15;141(4):1103-7.

PMID:2840462
Abstract

The expression and function of the T cell activation molecule Tp103 on human cloned cytotoxic CD3+ and CD3- cells were studied. All in vitro growing CD3+ and CD3- clones expressed Tp103 regardless of their phenotype and the expression of a CD3-associated TCR complex. Whereas the CD2 pathway was functional in all these clones, only CD3-expressing clones could be triggered via Tp103 to kill target cells. In contrast, both CD2 and Tp103 pathways were suppressed after modulation of the TCR complex with anti-CD3 mAb. This indicates that the function of Tp103 but not of CD2 is dependent on the expression of a functional Ag receptor on cytotoxic T cells. Furthermore, modulation of the Ag receptor induces a state of unresponsiveness in cytotoxic T cells that cannot be attributed to just the removal of the CD3/TCR complex from the cell membrane.

摘要

研究了人克隆的细胞毒性CD3 +和CD3-细胞上T细胞活化分子Tp103的表达及功能。所有体外生长的CD3 +和CD3-克隆均表达Tp103,无论其表型以及与CD3相关的TCR复合物的表达情况如何。虽然CD2途径在所有这些克隆中均起作用,但只有表达CD3的克隆可通过Tp103被触发以杀伤靶细胞。相反,用抗CD3单克隆抗体调节TCR复合物后,CD2和Tp103途径均被抑制。这表明Tp103而非CD2的功能依赖于细胞毒性T细胞上功能性抗原受体的表达。此外,抗原受体的调节会在细胞毒性T细胞中诱导一种无反应状态,这不能仅仅归因于从细胞膜上去除CD3/TCR复合物。

相似文献

1
Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex.通过Tp103途径触发细胞毒性T淋巴细胞和自然杀伤细胞依赖于T细胞受体/CD3复合物的表达。
J Immunol. 1988 Aug 15;141(4):1103-7.
2
Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.通过CD2 50KD绵羊红细胞受体诱导和阻断CD2⁺、CD3⁻自然杀伤细胞以及CD2⁺、CD3⁺细胞毒性T淋巴细胞中的细胞溶解作用
J Immunol. 1986 Jun 1;136(11):3939-44.
3
Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.同种异体特异性T细胞受体γ、δ+T细胞克隆的自然杀伤(NK)样细胞毒性活性。不同的受体-配体相互作用介导NK样和同种异体特异性细胞毒性。
J Immunol. 1989 Jun 15;142(12):4161-8.
4
Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only.T细胞受体γδ⁺/CD3⁺ T淋巴细胞通过CD2诱导细胞溶解仅需通过T11.1表位触发。
J Immunol. 1989 Mar 15;142(6):1797-802.
5
Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.通过CD3 + 4 - 8 - 16 + T细胞受体αβ - 克隆对肿瘤细胞进行裂解,该克隆通过CD3和CD16激活位点、重组白细胞介素2和干扰素β1进行调节。
J Immunol. 1987 Mar 1;138(5):1627-33.
6
Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.抗CD3与佛波醇肉豆蔻酸酯乙酸酯对主要组织相容性复合体非限制性T细胞细胞毒性的调节。肿瘤细胞裂解过程中对CD3/T细胞受体复合物表达无需求。
J Immunol. 1988 May 1;140(9):3253-60.
7
Cytotoxic T lymphocyte triggering via CD16 is regulated by CD3 and CD8 antigens. Studies with T cell receptor (TCR)-alpha beta+/CD3+16+ and TCR-gamma delta+/CD3+16+ granular lymphocytes.通过CD16触发的细胞毒性T淋巴细胞受CD3和CD8抗原调节。对T细胞受体(TCR)-αβ+/CD3+16+和TCR-γδ+/CD3+16+颗粒淋巴细胞的研究。
J Immunol. 1990 May 1;144(9):3312-7.
8
Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.基于被感染细胞功能和表型的变化,I型人类T细胞白血病/淋巴瘤病毒对一个CD4 +增殖性/细胞毒性T细胞克隆的感染至少会经历两个不同阶段。
J Immunol. 1989 Apr 1;142(7):2279-89.
9
Antigenic, functional, and molecular genetic studies of human natural killer cells and cytotoxic T lymphocytes not restricted by the major histocompatibility complex.不受主要组织相容性复合体限制的人类自然杀伤细胞和细胞毒性T淋巴细胞的抗原性、功能性及分子遗传学研究。
Fed Proc. 1986 Nov;45(12):2823-8.
10
Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.通过CD2/T11激活人细胞溶解细胞。T细胞和NK细胞诱导和介导肿瘤靶细胞裂解的条件比较。
J Immunol. 1989 Jun 1;142(11):4105-12.

引用本文的文献

1
The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.免疫系统和炎症性疾病(包括动脉粥样硬化)中的二肽基肽酶家族、脯氨酰寡肽酶和脯氨酰羧肽酶
Front Immunol. 2015 Aug 7;6:387. doi: 10.3389/fimmu.2015.00387. eCollection 2015.
2
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function.二肽基肽酶4抑制作为心脏代谢疾病的一种治疗策略:肠促胰岛素依赖性和非依赖性功能
Int J Cardiol. 2015 Oct 15;197:170-9. doi: 10.1016/j.ijcard.2015.06.076. Epub 2015 Jun 27.
3
Distribution of dipeptidyl peptidase IV in patients with chronic tonsillitis.
慢性扁桃体炎患者中二肽基肽酶IV的分布
Clin Vaccine Immunol. 2008 May;15(5):794-8. doi: 10.1128/CVI.00054-07. Epub 2008 Apr 2.
4
Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.胰岛素调节氨肽酶在肾素-血管紧张素片段血管紧张素IV作用中的参与:综述
Heart Fail Rev. 2008 Sep;13(3):321-37. doi: 10.1007/s10741-007-9062-x. Epub 2007 Nov 8.
5
Identification of novel regulators in T-cell differentiation of aplastic anemia patients.再生障碍性贫血患者T细胞分化中新型调节因子的鉴定。
BMC Genomics. 2006 Oct 19;7:263. doi: 10.1186/1471-2164-7-263.
6
Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15.IL-2、IL-12或IL-15诱导人自然杀伤细胞上2B9抗原/二肽基肽酶IV/CD26的表达
Immunology. 1997 May;91(1):151-8. doi: 10.1046/j.1365-2567.1997.00230.x.
7
Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.可溶性CD26/二肽基肽酶IV增强抗原诱导的T细胞增殖
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3082-6. doi: 10.1073/pnas.91.8.3082.
8
T cell targeting in cancer therapy.癌症治疗中的T细胞靶向治疗。
Cancer Immunol Immunother. 1991;34(1):1-8. doi: 10.1007/BF01741317.
9
CD26 induces T-cell proliferation by tyrosine protein phosphorylation.CD26 通过酪氨酸蛋白磷酸化诱导 T 细胞增殖。
Immunology. 1992 Sep;77(1):43-50.